Journal of
eISSN: 2373-633X
Submit manuscript...
Research Article Volume 17 Issue 1
Three year experience of chemoport insertion in 177 cancer patients at a tertiary care centre: outcomes and complications
Dr Aditi Agrawal, Dr Heena Doshi, Dr Rajshri Kelkar
Consultant Breast and Laparoscopic Surgeon, Wockhardt Hospital, India
Surgical Registrar, Wockhardt Hospital, India
Consultant General Surgeon, Saifee Hospital, India
Received: March 10, 2026 | Published: March 17, 2026
Citation: Agrawal A, Doshi H, Kelkar R. Three‑year experience of chemoport insertion in 177 cancer patients at a tertiary care centre: outcomes and complications. J Cancer Prev Curr Res. 2026;17(1):20‒24. DOI: 10.15406/jcpcr.2026.17.00601
Abstract
Background: Totally implantable venous access devices (chemoports) are essential for long-term chemotherapy administration but are not popular as they are associated with infectious and mechanical complications. Methods: This retrospective observational study was conducted at a tertiary care center over a 3-year period. Medical records of 177 consecutive patients who underwent chemoport insertion for chemotherapy were reviewed. All devices were inserted using ultrasoundguided internal jugular vein access under strict aseptic precautions, with use of chemoport reservoir size according to patient built. All patients were followed for a minimum of 6 months to evaluate infectious, wound-related, thrombotic, and mechanical complications. Results: Successful placement was achieved in all patients. The overall complication rate was 4.52% (8/177). Port-related infection occurred in 3 patients (1.69%), wound gape in 3 patients (1.69%), catheter-related thrombosis in 1 patient (0.56%), and port kink in 1 patient (0.56%). No major intraoperative complications were observed. A total of 95.5% of patients had no complications. Conclusion: Ultrasound-guided internal jugular vein access combined with meticulous sterile technique and use of chemoport reservoir size according to patient built is a safe and effective method for chemoport placement, demonstrating a low infection and complication rate.
Keywords: chemoport, totally implantable venous access device, internal jugular vein, infection rate, chemotherapy, complications
©2026 Agrawal, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.